Update on nanoparticle albumin-bound paclitaxel

Clinical Advances in Hematology and Oncology

Volumn 4, Issue 10, 2006, Pages 745-746

  Socinski, Mark ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CARBOPLATIN; CREMOPHOR; DOCETAXEL; GEMCITABINE; PACLITAXEL; TUBULIN;

ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG APPROVAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG PROTEIN BINDING; DRUG SOLUBILITY; DRUG TARGETING; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; NANOPARTICLE; NEUROPATHY; NEUTROPENIA; OVARY CANCER; SOLID TUMOR; THROMBOCYTOPENIA;

ALBUMINS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG NEOPLASMS; NANOPARTICLES; PACLITAXEL; SERUM ALBUMIN;

EID: 33751264855     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Belani CP, Barstis J, Perry MC, et al. Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation. J Clin Oncol. 2003;21:2933-2939.
2. Allerton JP, Hagenstad CT, Webb RT, et al; Online Collaborative Oncology Group. A phase II evaluation of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC). J Clin Oncol. 2006;24(18S). Abstract 7127.
3. Hawkins MJ, Georgy M, Makhson A, et al. Dose escalation study of nab-paclitaxel followed by carboplatin as first line therapy in advanced non-small cell lung cancer (NSCLC). J Clin Oncol. 2006;24(18S). Abstract 7132.
4. Gradishar WJ, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol. 2005;23:7794-7803.